Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DCF-013 | 3,′6-d isinapoyl sucrose |
>98%,Standard References
More description
|
![]() |
DCZ-251 | Sanguinarine Sulfate |
>98%,Standard References
More description
|
![]() |
DCY-134 | O-diacetyldaurisoline |
>98%,Standard References
More description
|
![]() |
DCS-085 | R-Notoginsenoside R2 |
>98%,Standard References
More description
|
![]() |
DCY-089 | alpha-boswellic acid,3-acetyl |
>98%,Standard References
More description
|
![]() |
DCY-090 | beta-boswellic acid,3-acetyl,11-keto |
>98%,Standard References
More description
|
![]() |
DCJ-047 | 25-OCH3-Protopanaxtiol |
>98%,Standard References
More description
|
![]() |
DCJ-060 | 3’-Methoxy apiin;Chrysoeiol-7-(2-O-apiosylglucoside) |
>98%,Standard References
More description
|
![]() |
DCJ-068 | Sanguinarine citrate |
>98%,Standard References
More description
|
![]() |
DCG-023 | Epimeredinoside A |
>98%,Standard References
More description
|
![]() |
DCY-175 | Icarisid II |
>98%,Standard References
More description
|
![]() |
DCS-097 | 1,3,5,8-Tetrahydroxylxanthone |
>98%,Standard References
More description
|
![]() |
DCS-112 | Ochnaflavone7-O-β-D-gluco-pyranoside |
>98%,Standard References
More description
|
![]() |
DCY-129 | Acetytastragaloside |
>98%,Standard References
More description
|
![]() |
DCF-009 | beta-rosasterol |
>98%,Standard References
More description
|
![]() |
DCY-141 | Yejunualactone |
>98%,Standard References
More description
|
![]() |
DCJ-050 | 3’-methoxy-5’-hydroxyisoflavone-7-O-β-D-glucoside |
>98%,Standard References
More description
|
![]() |
DCY-113 | Acevaltratum |
>98%,Standard References
More description
|
![]() |
DCY-142 | Ginkgolic acids |
>98%,Standard References
More description
|
![]() |
DCZ-129 | Panax notoginsenosides |
>98%,Standard References
More description
|
![]() |
DCZ-153 | paclitaxtide |
>98%,Standard References
More description
|
![]() |
DC12522 | MKK7-COV-3 Featured |
MKK7-COV-3 (MKK7 Covalen inhibitor 3) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 5 nM, displays >1,000-fold selectivity over MKK4 (IC50=7.81 uM), shows EC50 of 1.3 uM for reduction of p-JNK in ICW assays in Beas2B cell line, wit
More description
|
![]() |
DC22215 | RO 27-3225 Featured |
RO 27-3225 (RO27-3225, RO 273225) is a potent, selective melanocortin melanocortin receptor MC4R agonist with EC50 of 1 nM, >30-fold selectivity over MC3R.
More description
|
![]() |
DC21644 | SHP504 Featured |
SHP504 is a distinct, allosteric site 2 SHP2 inhibitor with IC50 of 21 uM (SHP2 1-525), and selective over the phosphatase domain (SHP2 PTP IC50>100 uM).downregulates DUSP6 mRNA, a downstream MAPK pathway marker, in KYSE-520 cancer cells.
More description
|
![]() |
DC39094 | JHU395 |
JHU395 is a novel orally bioavailable GA (glutamine antagonists) prodrug designed to circulate inert in plasma, but permeate and release active GA within target tissues. JHU395 delivers active GA to malignant peripheral nerve sheath tumor (MPNST), and significantly inhibits tumor growth without observed toxicity.
More description
|
![]() |
DC39081 | BCH |
BCH (LAT1-IN-1) is a selective and competitive inhibitor of system L amino acid transporter 1 (LAT1). BCH (LAT1-IN-1) induces apoptosis in cancer cells.
More description
|
![]() |
DC33598 | GSK-805 Featured |
GSK805, also known as ROR gamma-t-IN-1, is a potent, orally bioavailable retinoid-related orphan receptor gamma t (RORγt) inverse agonist that interacts with the receptor's putative ligand binding domain without exerting significant effects on DNA binding.
More description
|
![]() |
DC20613 | A-800141 |
A-800141 is a potent, highly specific, orally bioavailable MetAP2 inhibitor with IC50 of 12 nM, shows no inhibition for MetAP1 (IC50>30 uM).
More description
|
![]() |
DC26022 | Tenofovir exalidex(CMX157) |
Tenofovir exalidex is a novel lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir.
More description
|
![]() |
DC25028 | AUDA Featured |
A potent inhibitor of sEH (soluble epoxide hydrolase) with IC50 of 18 nM and 69 nM for mouse sEH and human sEH, respectively.
More description
|
![]() |